Section of Immunopathology, Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Drive, 10/10N103, 20892-1857, Bethesda, MD, USA,
Adv Exp Med Biol. 2014;801:193-8. doi: 10.1007/978-1-4614-3209-8_25.
The pathology of age-related macular degeneration (AMD) is characterized by degeneration of photoreceptors and retinal pigment epithelial cells as well as by changes of choroidal capillaries in the macula. Although AMD is not a typical uveitis, there is a consistence and an imbalance of ocular para-inflammation. Ocular inflammation, particularly in the macula, plays a critical role in AMD pathogenesis. The inflammatory and immune-related elements involved in AMD include inflammatory and related cells as well as the secreted molecules and factors from these cells. Innate immune system elements such as macrophages and cytokines play an important role in AMD pathology and pathogenesis. This chapter reviews the observed deviation in macrophage plasticity and the elevated expression of interleukin-17 in AMD eyes while discussing potential contributions to AMD pathogenesis. Targeting of these specific inflammatory pathways and molecules at appropriate times should be explored and may become promising novel adjunct agents to AMD therapy.
年龄相关性黄斑变性(AMD)的病理学特征为光感受器和视网膜色素上皮细胞的变性,以及黄斑部脉络膜毛细血管的改变。虽然 AMD 不是典型的葡萄膜炎,但存在一致性和眼旁炎症的失衡。眼部炎症,特别是在黄斑部,在 AMD 的发病机制中起着关键作用。涉及 AMD 的炎症和免疫相关因素包括炎症和相关细胞以及这些细胞分泌的分子和因子。先天免疫系统元素,如巨噬细胞和细胞因子,在 AMD 的病理学和发病机制中起着重要作用。本章通过讨论 AMD 发病机制中可能的贡献,综述了观察到的巨噬细胞可塑性偏差和白细胞介素-17 在 AMD 眼中的高表达。在适当的时候针对这些特定的炎症途径和分子进行靶向治疗,可能成为 AMD 治疗的有前途的新型辅助药物。